Replies to post #9497 on Aurinia Pharmaceuticals Inc (AUPH)

[Lunacy_John Galt]

I’ll be thrilled with any PR that says PH3 met the primary endpoint with good safety profile. I believe there is an 85%+ chance of success imo...with no math behind that, just speculating.

My aggressive opinion is that we might see CR rates at 50%+ due to better trail protocol while the endpoints are basically identical. There were many pearls that were identified during the initial trial, which helped them put together this PH3.